Bradycardia in a patient taking black cohosh

Medical Journal of Australia

Volumn 193, Issue 8, 2010, Pages 479-481

  McKenzie, Scott C ^a   Rahman, Atifur ^b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CIMICIFUGA RACEMOSA EXTRACT; ISOPRENALINE;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; CIMICIFUGA RACEMOSA; COMPLETE HEART BLOCK; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; HERBAL MEDICINE; HUMAN; MENOPAUSAL SYNDROME; SYNCOPE; TELEMETRY;

EID: 78149346465     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb04006.x     Document Type: Article

References (21)

1. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment - results of a large-scale, controlled, observational study. Maturitas 2007; 57: 405-414. (Pubitemid 47048608)
2. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms (protocol). Cochrane Database Syst Rev 2008; (3): CD007244. doi: 10.1002/14651858.CD007244.
3. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008; 199: 455-466.
4. Borelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci 2003; 73: 1215-1229.
5. Mahady GB, Low Dog T, Barrett ML, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15 (4 Pt 1): 628-638.
6. European Medicines Agency Committee on Herbal Medicinal Products. Annex 1: Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). London: EMEA, 8 May 2007. http://www.emea.europa.eu/pdfs/ human/hmpc/26925806en.pdf (accessed Sep 2009).
7. Therapeutic Goods Administration Adverse Drug Reactions Advisory Committee. Hepatotoxicity with black cohosh. Aust Adverse Drug React Bull 2006; 25 (2). http://www.tga.gov.au/adr/aadrb/aadr0604.htm#a1 (accessed Sep 2009).
8. Frempong W, Kiuru A, Ericsson J, Farah M. Cimicifuga racemosa L. Nutt. (black cohosh) and anaphylactic reactions, including face and oral oedema. Uppsala, Sweden: Uppsala Monitoring Centre. http:// www.who-umc.org/graphics/ 6998.pdf (accessed Sep 2009).
9. Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol 2007; 56 (5 Suppl): S124-S126. (Pubitemid 46552063)
10. Minciullo PL, Saija A, Patafi M, et al. Muscle damage induced by black cohosh (Cimicifuga racemosa). Phytomedicine 2006; 13: 115-118. (Pubitemid 41797599)
11. Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm 1999; 56: 1400-1402.
12. Mills S, Bone K. Principles and practice of phytotherapy: modern herbal medicine. Edinburgh: Churchill Livingstone, 2000.
13. Nuntanakorn P, Jiang B, Einbond LS, et al. Polyphenolic constituents of Actaea racemosa. J Nat Prod 2006; 69: 314-318.
14. Powell SL, Gödecke T, Nikolic D, et al. In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent. J Agric Food Chem 2008; 56: 11718-11726.
15. Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003; 51: 5661-5670.
16. Gödecke T, Nikolic D, Lankin DC, et al. Phytochemistry of cimicifugic acids and associated bases in Cimicifuga racemosa root extracts. Phytochem Anal 2009; 20: 120-133.
17. Tsukamoto S, Aburatani M, Ohta T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). Evid Based Complement Alternat Med 2005; 2: 223-226. (Pubitemid 41399496)
18. Horiuchi J, McDowall LM, Dampney RA. Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation. Auton Neurosci 2008; 142: 71-76.
19. Villela DC, da Silva LG Jr, Fontes MA. Activation of 5-HT receptors in the periaqueductal gray attenuates the tachycardia evoked from dorsomedial hypothalamus. Auton Neurosci 2009; 148: 36-43.
20. Noguchi M, Nagai M, Koeda M, et al. Vasoactive effects of cimicifugic acids C and D, and fukinolic acid in cimicifuga rhizome. Biol Pharm Bull 1998; 21: 1163-1168. (Pubitemid 28551437)
21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245. (Pubitemid 12149145)